ASX · EYE.AX
Nova Eye Medical Limited
A$0.15A$0.00 (0.0%)
Nova Eye Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 26.83% below the high.
Loading market information…
ASX · LGP.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 04:06 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Little Green Pharma Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Little Green Pharma Ltd’s next earnings report is currently expected on Nov 19, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Little Green Pharma Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| A$5.35M-56.86% vs estimate |
| Q2 2023 | Nov 29, 2022 | -A$0.03 | A$9.16M-50.76% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.15A$0.00 (0.0%)
Nova Eye Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 26.83% below the high.
A$0.15A$0.00 (0.0%)
Next Science Limited’s quoted price sits in the upper half of its reported 52-week range, 6.45% below the high.
A$0.04+A$0.00 (0.0%)
Emyria Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
A$0.08+A$0.00 (+5.0%)
BCAL Diagnostics Limited’s quoted price sits in the lower half of its reported 52-week range, 45.81% below the high.
A$0.03-A$0.00 (-1.43%)
Microba Life Sciences Limited’s quoted price sits in the lower half of its reported 52-week range, 67.14% below the high.
A$0.14A$0.00 (0.0%)
INOVIQ Ltd’s quoted price sits in the lower half of its reported 52-week range, 76.11% below the high.
A$0.04-A$0.00 (-2.22%)
IDT Australia Limited’s quoted price sits in the lower half of its reported 52-week range, 29.03% below the high.
A$0.02-A$0.00 (-4.76%)
Althea Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
